HIF1A and neoplasm: Silibinin inhibited the mTOR/p70S6K/4E-BP1 signaling pathway and HIF-1 activity in HeLa cells and Hep3B cells under hypoxia, and reduced the rate of HIF-1α protein synthesis and inhibited aerobic glycolysis in tumor cells (Garcia-Maceira and Mateo, 2009).